|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.5 TWD | +0.90% |
|
+0.45% | -14.93% |
| 14/05 | EPS Bio Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 08/05 | EPS Bio Technology Corp. Approves Dividend for the Year 2023 | CI |
EPS Bio Technology Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 463.45 million compared to TWD 480.28 million a year ago.
Net income was TWD 25.36 million compared to TWD 18.64 million a year ago. Basic earnings per share from continuing operations was TWD 1.07 compared to TWD 0.78 a year ago. Diluted earnings per share from continuing operations was TWD 1.06 compared to TWD 0.78 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.93% | 1.63Cr | |
| -4.22% | 1.24TCr | |
| -0.60% | 821.51Cr | |
| +6.61% | 571.74Cr | |
| -10.21% | 411.13Cr | |
| -60.42% | 268.39Cr | |
| +10.62% | 267.87Cr | |
| -5.50% | 237.39Cr | |
| +15.78% | 206Cr | |
| -9.18% | 180.32Cr |
EPS BIO TECHNOLOGY CORP. 
